542 related articles for article (PubMed ID: 34530915)
1. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
[TBL] [Abstract][Full Text] [Related]
2. HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity.
Amoroso A; Magistroni P; Vespasiano F; Bella A; Bellino S; Puoti F; Alizzi S; Vaisitti T; Boros S; Grossi PA; Trapani S; Lombardini L; Pezzotti P; Deaglio S; Brusaferro S; Cardillo M;
Transplantation; 2021 Jan; 105(1):193-200. PubMed ID: 33141807
[TBL] [Abstract][Full Text] [Related]
3. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
Front Immunol; 2020; 11():605688. PubMed ID: 33343579
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid.
Balas A; Moreno-Hidalgo MÁ; de la Calle-Prieto F; Vicario JL; Arsuaga M; Trigo E; de Miguel-Buckley R; Bellón T; Díaz-Menéndez M
Hum Immunol; 2023 Nov; 84(11):571-577. PubMed ID: 37777360
[TBL] [Abstract][Full Text] [Related]
5. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients.
Ebrahimi S; Ghasemi-Basir HR; Majzoobi MM; Rasouli-Saravani A; Hajilooi M; Solgi G
Hum Immunol; 2021 Oct; 82(10):719-725. PubMed ID: 34294460
[TBL] [Abstract][Full Text] [Related]
7. Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection.
Fischer JC; Balz V; Jazmati D; Bölke E; Freise NF; Keitel V; Feldt T; Jensen BO; Bode J; Lüdde T; Häussinger D; Adams O; Schneider EM; Enczmann J; Rox JM; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Gerber PA; Lichtenberg A; Schelzig H; Flaig Y; Rezazadeh A; Budach W; Matuschek C
Eur J Med Res; 2022 Nov; 27(1):255. PubMed ID: 36411478
[TBL] [Abstract][Full Text] [Related]
8. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; López-Ruz MÁ; Martín-Casares AM; Fernández-Rubiales A; Anderson P; Garrido F; Ruiz-Cabello F; López-Nevot MÁ
J Microbiol Immunol Infect; 2022 Jun; 55(3):421-427. PubMed ID: 34475005
[TBL] [Abstract][Full Text] [Related]
9. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y
J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837
[TBL] [Abstract][Full Text] [Related]
10. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity.
Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F
Front Immunol; 2022; 13():769900. PubMed ID: 35185875
[TBL] [Abstract][Full Text] [Related]
11. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
Migliorini F; Torsiello E; Spiezia F; Oliva F; Tingart M; Maffulli N
Eur J Med Res; 2021 Aug; 26(1):84. PubMed ID: 34344463
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.
Astbury S; Reynolds CJ; Butler DK; Muñoz-Sandoval DC; Lin KM; Pieper FP; Otter A; Kouraki A; Cusin L; Nightingale J; Vijay A; Craxford S; Aithal GP; Tighe PJ; Gibbons JM; Pade C; Joy G; Maini M; Chain B; Semper A; Brooks T; Ollivere BJ; McKnight Á; Noursadeghi M; Treibel TA; Manisty C; Moon JC; ; Valdes AM; Boyton RJ; Altmann DM
Immunology; 2022 May; 166(1):68-77. PubMed ID: 35156709
[TBL] [Abstract][Full Text] [Related]
13. HLA alleles associated with susceptibility and severity of the COVID-19 in Vietnamese.
Hai NTT; Nhung VP; Tam NTT; Ngoc TTB; Thuong MTH; Dai HV; Duong NT; Hai NV; Ton ND; Thach PN; Ha NH
Hum Immunol; 2024 May; 85(3):110796. PubMed ID: 38580537
[TBL] [Abstract][Full Text] [Related]
14. Association study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Paraná, Brazil.
Muxel SM; Borelli SD; Amarante MK; Voltarelli JC; Aoki MN; de Oliveira CE; Ehara Watanabe MA
J Clin Lab Anal; 2008; 22(4):229-33. PubMed ID: 18623133
[TBL] [Abstract][Full Text] [Related]
15. The influence of HLA genotype on the severity of COVID-19 infection.
Langton DJ; Bourke SC; Lie BA; Reiff G; Natu S; Darlay R; Burn J; Echevarria C
HLA; 2021 Jul; 98(1):14-22. PubMed ID: 33896121
[TBL] [Abstract][Full Text] [Related]
16. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.
Kuzushita N; Hayashi N; Moribe T; Katayama K; Kanto T; Nakatani S; Kaneshige T; Tatsumi T; Ito A; Mochizuki K; Sasaki Y; Kasahara A; Hori M
Hepatology; 1998 Jan; 27(1):240-4. PubMed ID: 9425943
[TBL] [Abstract][Full Text] [Related]
17. Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia.
Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
Virology; 2021 Aug; 560():1-7. PubMed ID: 34015620
[TBL] [Abstract][Full Text] [Related]
18. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
19. Association between the HLA genotype and the severity of COVID-19 infection among South Asians.
Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
J Med Virol; 2021 Jul; 93(7):4430-4437. PubMed ID: 33830530
[TBL] [Abstract][Full Text] [Related]
20. The humoral and cellular response to mRNA SARS-CoV-2 vaccine is influenced by HLA polymorphisms.
Bertinetto FE; Magistroni P; Mazzola GA; Costa C; Elena G; Alizzi S; Scozzari G; Migliore E; Galassi C; Ciccone G; Ricciardelli G; Scarmozzino A; Angelone L; Cassoni P; Cavallo R; Vaisitti T; Deaglio S; Amoroso A;
HLA; 2023 Sep; 102(3):301-315. PubMed ID: 37010080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
